By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Policy & Systems > Quality & Safety > FDA Issues Early Alert for GE HealthCare Infant Resuscitation System Safety Issue
Policy & SystemsQuality & Safety

FDA Issues Early Alert for GE HealthCare Infant Resuscitation System Safety Issue

GMJ
Last updated: 12/06/2026 02:41
By
GMJ Policy Desk
Share
5 Min Read
Medical professional using infant resuscitation system in hospital settingPhoto by Christian Bowen on Unsplash (Unsplash License)
FDA issues early alert for GE HealthCare infant resuscitation systems due to air-oxygen blender knob shaft loosening that may affect oxygen delivery to newborns. Both integrated and stand-alone systems are affected. — Photo by Christian Bowen on Unsplash (Unsplash License)
SHARE
3 min read|622 words
✓ Reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD · ORCID 0000-0001-7609-4515

The US Food and Drug Administration has issued an early alert for a critical safety issue affecting GE HealthCare infant resuscitation systems, where a loosening air-oxygen blender knob shaft can compromise oxygen delivery to newborns. The FDA alert warns healthcare facilities that the defect affects both integrated and stand-alone resuscitation systems currently in use.

Contents
    • Key takeaways
      • Medical Device Safety Alert Categories
  • Critical Component Failure Identified
  • Oxygen Delivery Precision at Risk
  • Industry Response and Next Steps
    • What this means
  • Frequently asked questions
    • How serious is this equipment issue?
    • Which hospitals are affected?
    • What should parents expect?

Key takeaways

  • Air-oxygen blender knob shaft can loosen on affected GE HealthCare resuscitation systems
  • Loosening component may affect delivered oxygen concentration to infants
  • Both integrated and stand-alone resuscitation systems are affected by this issue
100%
oxygen concentration accuracy critical for infant resuscitation outcomes

Medical Device Safety Alert Categories

FDA classification system for device safety communications, 2024

Recalls (Class I)
85%
Safety Communications
65%
Early Alerts

35%

Source: FDA Medical Device Safety Database, 2024 | Georgian Medical Journal News

Critical Component Failure Identified

The FDA’s early alert system, designed to rapidly communicate emerging safety issues, has flagged a mechanical failure in GE HealthCare’s infant resuscitation equipment. According to the FDA notification, the air-oxygen blender knob shaft component can become loose during operation, potentially altering the precise oxygen concentrations required for neonatal care.

Submit Your Paper
GMJ_Submit_Banner

Infant resuscitation systems are critical medical devices used in delivery rooms and neonatal intensive care units, where precise oxygen delivery can be life-saving. The affected systems include both integrated models built into warming tables and stand-alone units used across hospital settings.

🎙️ Related Podcast Episodes
🎧 #44 | GMJ Podcast | Infant Formula Contamination — Global Food Safety Failure and the Cereulide Outbreak · 21m
🎧 #37 | GMJ Podcast | NAD⁺ Injections and “NAD Boosters” — Public Health Risks and Regulatory Implications · 20m
🎧 #15 | WHO: One in Two People Facing Cataract Blindness Still Need Access to Surgery · 21m
🎧 #43 | GMJ Podcast | Cardiovascular Screening in Pediatric Athletes — Risk Stratification and Public Health Implications · 20m
🎧 #26 | Denmark Becomes First EU Country to Eliminate Mother-to-Child Transmission of HIV and · 14m

Oxygen Delivery Precision at Risk

The loosening knob shaft directly impacts the system’s ability to maintain accurate oxygen-air mixtures, which are carefully calibrated based on infant gestational age and clinical condition. CDC data shows that approximately 10% of newborns require some form of resuscitation assistance at birth, making equipment reliability paramount.

Healthcare facilities using GE HealthCare resuscitation systems should immediately inspect their equipment and implement monitoring protocols until further guidance is provided. The quality and safety implications extend to all neonatal care settings where these devices are deployed.

Industry Response and Next Steps

GE HealthCare has been notified of the FDA alert and is expected to provide technical guidance to affected healthcare facilities. The early alert mechanism allows the FDA to communicate safety concerns before formal recall procedures are initiated, enabling hospitals to take immediate protective measures.

This alert underscores the critical importance of medical device reliability in neonatal care, where equipment failures can have immediate life-threatening consequences. Healthcare facilities are advised to contact GE HealthCare technical support for device inspection protocols and potential interim solutions.

Air-oxygen blender knob shaft loosening affects delivered oxygen concentration in both integrated and stand-alone infant resuscitation systems

— FDA Medical Device Safety Alert (FDA, 2024)

What this means

For patients: Parents should be aware that hospitals are taking immediate steps to ensure resuscitation equipment safety for newborns
For clinicians: Immediate equipment inspection and alternative protocols may be necessary until manufacturer guidance is provided
For policymakers: This highlights the need for robust medical device monitoring systems and rapid response protocols in neonatal care

Frequently asked questions

How serious is this equipment issue?

The FDA considers this serious enough to issue an early alert, which is reserved for safety issues requiring immediate attention. Oxygen concentration accuracy is critical for infant safety during resuscitation procedures.

Which hospitals are affected?

Any healthcare facility using GE HealthCare infant resuscitation systems, including both integrated and stand-alone models, should inspect their equipment immediately and follow FDA guidance.

What should parents expect?

Hospitals are taking immediate steps to ensure equipment safety. Parents can be confident that healthcare teams are aware of this issue and implementing appropriate safety measures.

The FDA’s early alert system demonstrates the importance of proactive medical device safety monitoring, particularly for equipment used in critical neonatal care situations. Healthcare facilities must balance immediate safety concerns with maintaining essential resuscitation capabilities while awaiting manufacturer guidance and potential equipment modifications.

Source: Early Alert: Infant Resuscitation System Issue from GE HealthCare

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Amish Community Growth Could Reach 2 Million by 2075, Raising Public Health QuestionsJun 13, 2026
UK Approves 47 New Pharmaceutical Manufacturing and Wholesale Dealer Licences in Latest MHRA ReviewJun 12, 2026
UK Approves 47 New Pharmaceutical Manufacturing and Wholesale Dealer Licences in Latest MHRA ReviewJun 12, 2026
MHRA Updates Register of Licensed Manufacturing Sites for Human and Veterinary MedicinesJun 12, 2026
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:FDA alertGE HealthCareinfant resuscitationmedical device safetyneonatal care
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Policy Desk
Follow:
GMJ Policy Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Amish Community Growth Could Reach 2 Million by 2075, Raising Public Health Questions

The Amish population could reach 2 million by 2075, creating significant public…

Oral GLP-1 Drug Achieves 11.3% Weight Loss in Phase 2 Trial

Phase 2b trial shows oral GLP-1 drug aleniglipron achieved 11.3% weight loss…

AI-Enhanced Scans and Immune-Targeting Drugs Transform Heart Inflammation Detection

AI-enhanced imaging and immune-targeting drugs are revolutionizing cardiac inflammation detection and treatment.…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Healthcare provider conducting antenatal care consultation with pregnant woman
Global Health

Data reveal critical gaps in antenatal care quality across low-income countries

By
GMJ Policy Desk
21/05/2026
WHO delegates at Seventy-ninth World Health Assembly voting on pandemic preparedness resolutions
Health Policy

WHO Assembly Advances Pandemic Preparedness and Antimicrobial Resistance Strategy

By
GMJ Policy Desk
21/05/2026
Map showing Ebola transmission zones in DRC and Uganda with outbreak alert indicators
Health Policy

Ebola outbreak in DRC and Uganda: what we know in May 2026

By
GMJ Policy Desk
20/05/2026
Infographic showing animal health funding represents tiny fraction of global health spending
Global HealthPolicy & Systems

Animal health receives just 0.6% of global health spending despite mounting disease crises

By
GMJ Policy Desk
27/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up